Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | RBP4 | P02753 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.33 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9248714 | 0.84 | ALDH1A1 (0.33) | ALDH1A1TDP1TSHRCA2 | |
| SCHEMBL7292118 | 0.82 | ALDH1A1 (0.32) | ALDH1A1TDP1TSHR | |
| SCHEMBL634438 | 0.80 | CA2 (0.41) | ALDH1A1TDP1TSHRCA2RBP4 | |
| SCHEMBL10600545 | 0.79 | NPC1 (0.36) | ALDH1A1TDP1TSHRATM | |
| SCHEMBL11390596 | 0.78 | CA2 (0.36) | ALDH1A1TDP1TSHRCA2RBP4 | |
| SCHEMBL717061 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL179312 | 0.76 | TSHR (0.50) | ALDH1A1TDP1TSHRCA2GAA | |
| SCHEMBL3148798 | 0.76 | TSHR (0.35) | TSHR | |
| SCHEMBL8099528 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TDP1TSHRCA2RBP4 | |
| SCHEMBL4590165 | 0.76 | ALDH1A1 (0.44) | ALDH1A1TDP1TSHRCA2GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4131539-A1 | ELECTROCHEMICAL DEVICE | Amperex Technology Limited (HK) | 2023-02-08 | — | — | EP | claimed |
| CN-114681473-A | Application of glucosamine and derivatives thereof as anti-novel coronavirus drugs | 南湖实验室 | 2022-07-01 | — | — | CN | claimed |
| CN-112336733-A | Application of glucosamine and derivatives thereof as anti-novel coronavirus drugs | 南湖实验室 | 2021-02-09 | — | — | CN | claimed |
| EP-3682029-A1 | DETECTION OF RECOMBINASE POLYMERASE AMPLIFICATION USING DUAL-HAPTEN PROBE | Alere San Diego Inc. (US) | 2020-07-22 | — | — | EP | claimed |
| CN-111201328-A | Detection of amplification of recombinant enzyme polymerase using dual hapten probes | 爱乐圣地亚哥公司 | 2020-05-26 | — | — | CN | claimed |
| CN-110806677-A | Photoresist composition, pattern forming method and application thereof | 常州强力先端电子材料有限公司 | 2020-02-18 | — | — | CN | claimed |
| CN-107382874-B | The preparation method and applications of a kind of chirality six-membered heterocycle carbene precursor salt | 浙江大学城市学院 | 2019-11-22 | — | — | CN | claimed |
| CN-110256221-A | A kind of synthetic method of 2- alkyl-anthraquinone | 宜昌苏鹏科技有限公司 | 2019-09-20 | — | — | CN | claimed |
| WO-2019055780-A1 | DETECTION OF RECOMBINASE POLYMERASE AMPLIFICATION USING DUAL-HAPTEN PROBE | ALERE SAN DIEGO INC. (US) | 2019-03-21 | — | — | WO | claimed |
| EP-3162819-B1 | IMPROVED ZIEGLER-NATTA CATALYST SYNTHESIS AND PROCESS THEREOF | INDIAN OIL CORP LTD (IN) | 2018-09-05 | — | — | EP | claimed |
| WO-2008060998-A1 | INDOLE SULFONAMIDES AS SFRP-1 MODULATORS | WYETH (US) | 2008-05-22 | — | — | WO | claimed |
| WO-2005073336-A1 | METHODS OF REDUCING SAG IN NON-AQUEOUS FLUIDS | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2005-08-11 | — | — | WO | claimed |
| US-20050059817-A1 | Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives | SIRNA THERAPEUTICS, INC. (US) | 2005-03-17 | — | — | US | claimed |
| EP-0620216-B1 | Benzamide derivatives and their use as vasopressin antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-01-08 | — | — | EP | claimed |
| US-20020150936-A1 | Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives | RIBOZYME PHARMACEUTICALS, INC. | 2002-10-17 | — | — | US | claimed |
| EP-0532752-B1 | COMPOUND TAN-1251, ITS DERIVATIVES, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-12-16 | — | — | EP | claimed |
| US-4774332-A | LIGHT STABILIZERS FOR POLYMERS | SANDOZ, LTD. (CH) | 1988-09-27 | — | — | US | claimed |
| US-4754034-A | RECORDING MATERIALS, PRESSURE SENSITIVE, THERMOREACTIVE, ELECTROCHROMIC | BAYER AKTIENGESELLSCHAFT (DE) | 1988-06-28 | — | — | US | claimed |
| EP-0180813-B1 | CHROMOGENIC 4,4-DIARYLDIHYDROCHINAZOLONES, THEIR PREPARATION AND USE | BAYER AG (DE) | 1988-06-01 | — | — | EP | claimed |
| EP-0180813-A1 | Chromogenic 4,4-diaryldihydrochinazolones, their preparation and use | BAYER AG (DE) | 1986-05-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059817-A1 | Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives | PNP, NSUN2, NT5C3B | ALDH1A1 2429/4885TDP1 1161/4885TSHR 4580/4885 |
| US-20020150936-A1 | Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives | PNP, NSUN2, NT5C3B | ALDH1A1 2830/4885TDP1 1182/4885TSHR 4568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.